Escalier Biosciences
Sander Van Deventer is an advisor at Escalier Biosciences. Sander was previously a CEO, CSO, and General Manager at uniQure, a Partner at Forbion Capital Partners, and a Professor at Leiden University Medical Center.
Sander Van Deventer studied at the University of Amsterdam, where they obtained their MD and PhD in Internal Medicine and Gastroenterology. Sander also studied at the Stedelijk Gymnasium Haarlem.
This person is not in the org chart
This person is not in any offices
Escalier Biosciences
Escalier Biosciences is developing both topical and oral RORγt inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would benefit from a safe and effective topical RORγt therapeutic to the more moderate-to-severe patients that would benefit from a safe and effective oral RORγt drug in lieu of injectable biologic therapies targeting IL-17 and IL-23.